Company
IONIS PHARMACEUTICALS INC
IONS · CIK 0000874015
Sale of 53 shares at $43.5389 per share.
Reporting Person Swayze Eric · Officer Title EVP Research · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0000874015-26-000266 · filed 2026-10-19 · View filing →
Sale of 1,357 shares at $43.5386 per share.
Reporting Person Devers Shannon L. · Officer Title EVP, Chief Human Resources Ofc · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0000874015-26-000267 · filed 2026-10-19 · View filing →
Acquisition (code M) of 125 shares at $0.0 per share.
Reporting Person Swayze Eric · Officer Title EVP Research · Transaction Code M
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0000874015-26-000266 · filed 2026-10-19 · View filing →
Acquisition (code M) of 2,820 shares at $0.0 per share.
Reporting Person Devers Shannon L. · Officer Title EVP, Chief Human Resources Ofc · Transaction Code M
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0000874015-26-000267 · filed 2026-10-19 · View filing →